MDX-1342

· Bristol-Myers Squibb

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for MDX-1342, covering 2013-05-22 to 2013-05-22. Get the full timeline:

Most recent: Clinical Trial Update: Study of the Safety of MDX-1342 in Combination With Methotrexate in Patients With Rheumatoid Arthritis [Phase 1]